Drug intelligence / Profile preview

hyperoxygenated fatty acids

Development stage
Unknown
Lead developer
Laboratorios Bama-Geve
Modality
Small Molecules
Administration
Topical
01

Overview

Hyperoxygenated fatty acids (HOFA) are a topical formulation, most notably marketed under the brand name Mepentol, used for the prevention and treatment of Stage I pressure ulcers (pressure injuries). Developed by Laboratorios Bama-Geve, the product is composed of a blend of essential fatty acids—primarily linoleic acid, along with gamma-linolenic, oleic, palmitic, stearic, palmitoleic, arachidonic, and eicosenoic acids—that have been subjected to an oxidative process. This formulation often includes plant extracts such as *Equisetum arvense* (horsetail) and *Hypericum perforatum* (St. John's Wort). The therapeutic effect is achieved by reinforcing the skin's epidermal barrier, promoting keratinocyte renewal, restoring capillary microcirculation to combat ischemia, and neutralizing oxygen free radicals produced during reactive hyperemia. It is specifically indicated for at-risk populations, including immobilized, malnourished, or elderly patients in both hospital and primary care settings.

Brand names
MepentolMepentol LecheLinoveraCorpitol
Other names
hyper-oxygenated fatty acidshyperoxygenated essential fatty acidsoxidized fatty acids

Beyond the preview

Go deeper on hyperoxygenated fatty acids.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on hyperoxygenated fatty acids.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call